ICH stability guidelines

The ICH stability guidelines are the internationally agreed rulebook for how to prove a medicine stays good for its stated life. Before they existed, a manufacturer wanting to sell in Europe, Japan and the USA had to run three different stability programmes; the ICH set harmonised this into one accepted standard, so a single well-designed study satisfies all three regions.

ICH stands for the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Its stability documents are the Q1 family: Q1A defines the core testing of new drug substances and products (including the storage conditions and a minimum 12-month long-term study), Q1B covers photostability, Q1C addresses new dosage forms, Q1D bracketing and matrixing designs, Q1E how to evaluate the data and extrapolate shelf life, and the related Q1F (and regional annexes) deal with climatic zones.

The guidelines specify standardised storage conditions tied to world climatic zones — for example long-term storage at 25 degrees Celsius/60 per cent relative humidity (or 30/65 in hotter zones), intermediate at 30/65, and accelerated at 40/75 — plus how many batches to test, how often to sample, and how to justify the proposed shelf life and storage statement from the resulting data.

A caveat on scope: ICH guidelines set the framework, but each regulatory authority can add regional requirements (for example specific climatic-zone conditions), and the guidance continues to evolve, so the current versions and local annexes must always be checked.